NeuroOne Medical Technologies Corporation Increase (Decrease) in Accounts Receivable
NeuroOne Medical Technologies Corporation (NMTC) reported Increase (Decrease) in Accounts Receivable of -$165.84 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$798.42K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$764.48K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.40M, a 36.27% decline year-over-year.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.26M.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for fiscal 2025 was $1.09M, a 516.05% increase from fiscal 2024.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for fiscal 2024 was $176.64K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for fiscal 2023 was -$33.24K.
- NeuroOne Medical Technologies Corporation increase (decrease) in accounts receivable for fiscal 2022 was -$15.10K, a 131.24% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$798.42K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2026-08-13 | -$1.56M derived: sum of 2 quarters · filed 2026-08-13 | -$165.84K 10-Q · filed 2026-08-13 | $1.10M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$764.48K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-06-12 | $632.58K 10-Q/A · filed 2026-06-12 | $1.16M 10-Q · filed 2026-05-12 | $1.90M derived: sum of 3 quarters · filed 2026-06-12 | $1.58M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.40M 10-Q · filed 2026-02-17 | $2.66M derived: sum of 2 quarters · filed 2026-02-17 | $2.34M derived: sum of 3 quarters · filed 2026-08-13 | $292.95K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $946.02K derived: sum of 2 quarters · filed 2026-08-13 | -$1.10M derived: sum of 3 quarters · filed 2026-08-13 | $1.09M 10-K · filed 2025-12-17 | |
| 2025-06-30 | -$318.78K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2026-08-13 | -$2.37M derived: sum of 2 quarters · filed 2026-08-13 | -$176.64K 10-Q · filed 2026-08-13 | -$410.55K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$2.05M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-06-12 | $142.14K 10-Q/A · filed 2026-06-12 | -$91.77K derived: sum of 3 quarters · filed 2026-06-12 | -$236.86K derived: sum of 4 quarters · filed 2026-06-12 | |
| 2024-12-31 | $2.19M 10-Q · filed 2026-02-17 | $1.96M derived: sum of 2 quarters · filed 2026-02-17 | $1.81M derived: sum of 3 quarters · filed 2026-02-17 | $1.83M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-09-30 | -$233.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | -$379.00K derived: sum of 2 quarters · filed 2025-12-17 | -$366.76K derived: sum of 3 quarters · filed 2025-12-17 | $176.64K 10-K · filed 2025-12-17 | |
| 2024-06-30 | -$145.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | -$132.85K derived: sum of 2 quarters · filed 2025-08-14 | $410.55K 10-Q · filed 2025-08-14 | $410.55K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $12.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | $555.64K 10-Q · filed 2025-05-13 | $555.64K derived: sum of 3 quarters · filed 2025-05-13 | $341.69K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $543.40K 10-Q · filed 2025-02-12 | $543.40K derived: sum of 2 quarters · filed 2025-02-12 | $329.45K derived: sum of 3 quarters · filed 2025-02-12 | $448.08K derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | -$213.95K derived: sum of 2 quarters · filed 2024-12-17 | -$95.32K derived: sum of 3 quarters · filed 2024-12-17 | -$33.24K 10-K · filed 2024-12-17 | |
| 2023-06-30 | -$213.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | -$95.32K derived: sum of 2 quarters · filed 2024-08-14 | -$33.24K 10-Q · filed 2024-08-14 | $0.00 derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $118.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | $180.72K 10-Q · filed 2024-05-14 | $213.95K derived: sum of 3 quarters · filed 2024-05-14 | $177.37K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $62.08K 10-Q · filed 2024-02-13 | $95.32K derived: sum of 2 quarters · filed 2024-02-13 | $58.73K derived: sum of 3 quarters · filed 2024-02-13 | $70.69K derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | $33.24K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | -$3.35K derived: sum of 2 quarters · filed 2023-12-15 | $8.61K derived: sum of 3 quarters · filed 2023-12-15 | -$15.10K 10-K · filed 2023-12-15 | |
| 2022-06-30 | -$36.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$24.63K derived: sum of 2 quarters · filed 2023-08-14 | -$48.34K 10-Q · filed 2023-08-14 | -$40.10K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $11.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$11.75K 10-Q · filed 2023-05-12 | -$3.51K derived: sum of 3 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$23.71K 10-Q · filed 2023-02-13 | -$15.47K derived: sum of 2 quarters · filed 2023-02-13 | |||
| 2021-09-30 | $8.24K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $48.34K 10-K · filed 2022-12-22 | |||
| 2021-06-30 | $40.10K 10-Q · filed 2022-08-11 | ||||
| 2020-12-31 | $71.47K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |